Jessica Maxwell

The University of Texas MD Anderson Cancer Center

Papers

4

Total Citations

29

H-Index

3

About

Jessica Maxwell is a surgical researcher whose work centers on improving outcomes in pancreatic surgery, with a particular focus on opioid reduction and complication prevention. Her major contributions include demonstrating that robotic pancreatoduodenectomy offers additional benefits in decreasing inpatient opioid use compared to open surgery, as shown in her highly cited 2022 study (16 citations). She has also established a critical link between postoperative opioid use and increased rates of Grade B/C pancreatic fistula after distal pancreatectomy (8 citations), providing evidence that guides safer pain management protocols. Beyond opioid stewardship, Maxwell has advanced the technical quality of robotic surgery for pancreatic cancer, authoring a video manuscript on superior mesenteric and hepatic artery dissection techniques. Her work on recalibrating drain fluid amylase removal criteria for risk-stratified pancreatoduodenectomy further refines postoperative monitoring. With a growing citation impact, Maxwell’s research directly shapes clinical pathways that balance effective pain control with reduced surgical complications, making her a key voice in the evolution of minimally invasive pancreatic surgery.

Research Focus

Key Achievements

3
H-Index
4
Papers
29
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Comparative analysis of opioid use between robotic and open pancreatoduodenectomy
16 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago